N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. by Noelia Carballeda-Sangiao (2889611)

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. by Kameljit K. Kalsi (16496511)

Effect of leucettines on the proliferation of MIN6 cells. by Barbara Pucelik (2988795)

Subjects:

Fluid loss and hydration in CON (n = 22) and HOT (n = 17) surgeries; Decrease in body mass in kg (A), decrease in body mass in % of total body mass (B), rate of decrease in body ma... by Zehra Palejwala (7507409)

The influence of DYRK1A inhibitors on MIN6 function: Flow cytometry analysis of insulin, C-peptide and glucagon expression in MIN6 cells. by Barbara Pucelik (2988795)

Subjects:

Effect of METTL3 and WTAP depletion in <i>Toxoplasma</i>. by Michael J. Holmes (3689758)

“…B) Quantitation of m6A levels after treatment of parasites with 500 μM IAA for 4 h. …”

Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

“…(d) Noise-evoked activity rates at different noise intensities for chronically tracked PV cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 31 neurons, mean ± SE). Activity rates decreased during repeated stress compared to baseline (2-way ANOVA, condition F = 49.6, <i>p</i> = 2.6 × 10⁻¹², condition: intensity interaction F = 1.94, <i>p</i> = 0.02, nested ANOVA (mouse nested within session), F = 56.5, <i>p</i> = 8.8 × 10⁻¹⁴, condition: intensity interaction F = 3.5, <i>p</i> = 3.5 × 10⁻⁰⁵). …”

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Subjects:

Viability of MIN6 cell lines treated with various pharmacological reagents. by Barbara Pucelik (2988795)

Subjects:

Schematic figure of a left ventricular pressure-volume loop with cardiovascular hemodynamics marked. by Björn Östenson (15447383)

The effect of investigated leucettines on the level of DYRK1A in MIN6 cells. by Barbara Pucelik (2988795)

Subjects:

The influence of selected leucettines on insulin production by 3D MIN6 spheroids. by Barbara Pucelik (2988795)

Subjects:

Transepithelial electrical resistance (TEER) (N = 6). by Shirko Marcel Shokr (19173337)

“…<p><b>(A)</b> During the cultivation of SMC and ALI we observed significantly differences on day 18 (SMC: 9.61 kΩ*cm²; ALI: 7.73 kΩ*cm²; p<0.05) and day 25 (SMC: 8.19 kΩ*cm²; ALI: 6.44 kΩ*cm²; p<0.05) ALI cultures showed significantly decreased values compared to SMC. …”

General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Conditional ablation of <i>Ybx1</i> leads to a reduction in cortical progenitor cell pool and a decrease in cortical thickness. by Jian Zhang (1682)

The influence of leucettines as DYRK1A inhibitors on insulin, C-peptide, and glucagon production by MIN6 cells. by Barbara Pucelik (2988795)

Subjects: